| May 15 2025 |
Clickbait: Actual Scope (Not Intended Scope) Determines Broadening Reissue Analysis |
McDermott Will & Emery |
| May 15 2025 |
Breaking New Grounds to Limits of IPR Estoppel |
McDermott Will & Emery |
| May 15 2025 |
No Article III Appellate Standing Under the Sun |
McDermott Will & Emery |
| May 15 2025 |
Hatch-Waxman or Not, Clinical Trials Aren’t Subject to Injunction |
McDermott Will & Emery |
| May 15 2025 |
No Protectable Code: No Literal or Nonliteral Copying |
McDermott Will & Emery |
| May 15 2025 |
Up in Smoke: Statutory Trademark Damages Can Exceed Actual Damages |
McDermott Will & Emery |
| May 14 2025 |
China’s State Council Releases 2025 Legislative Plan – Amended Trademark Law in the Works |
Schwegman, Lundberg & Woessner, P.A. |
| May 14 2025 |
Alice Patent Eligibility Analysis Divergence Before USPTO and District Court |
Foley & Lardner LLP |
| May 14 2025 |
China’s State Administration for Market Regulation Releases Top 10 Typical Cases of Intellectual Property Law Enforcement for 2024 |
Schwegman, Lundberg & Woessner, P.A. |
| May 13 2025 |
Alice Patent Eligibility Analysis Divergance before USPTO and District Court: Federal Circuit Clarifies Limits on Relying on USPTO Findings in § 101 Eligibility Disputes |
Foley & Lardner LLP |
| May 13 2025 |
Compelling Rationale for Producing Proprietary Products in U.S. Found in USTR’s Special 301 Report on IP Protection and Enforcement Abroad (Part I) |
Squire Patton Boggs (US) LLP |
| May 13 2025 |
Recentive v. Fox: Machine-Learning Claims Fail to Make the Grade |
Bracewell LLP |
| May 13 2025 |
AI Governance Remains Critical Despite Political Pendulum Swings |
Katten |
| May 13 2025 |
A Quest Against Middle-earth: Lord of the Fries Successfully Registers LORD OF THE Mark |
K&L Gates LLP |
| May 13 2025 |
California Supreme Court Prohibits Contractual Limitation of Liability Clauses for Intentional Misconduct |
Hinch Newman LLP |
| May 13 2025 |
Estoppel Estopped? |
K&L Gates LLP |
| May 12 2025 |
Copyright Office Report on Training AI and Fair Use |
Sheppard, Mullin, Richter & Hampton LLP |
| May 12 2025 |
A Line in the Sand: Federal Circuit Bounds IPR Estoppel in Ingenico v. IOENGINE |
Sheppard, Mullin, Richter & Hampton LLP |
| May 12 2025 |
Spring 2025 Kattison Avenue |
Katten |
| May 12 2025 |
China’s Supreme People’s Court and the Supreme People’s Procuratorate Release Typical Cases of Criminal IP Enforcement for 2024 |
Schwegman, Lundberg & Woessner, P.A. |
| May 9 2025 |
China Releases Typical Cases of Intellectual Property Protection by China Customs in 2024 – China Facing Imported Counterfeits Due to Manufacturing Moving to Other Countries |
Schwegman, Lundberg & Woessner, P.A. |
| May 9 2025 |
The Hypocrisy of “Delete IP”: Billionaire Frustrations Masquerading as Policy |
The National Law Review's Guest Contributors - NLR |
| May 9 2025 |
Pitfalls to Avoid Before Filing an Offensive Patent Litigation Case |
Winstead |
| May 8 2025 |
Leveraging and Protecting Trade Secrets in the 21st Century |
Financial Poise |
| May 8 2025 |
Paint It White: No Sovereign Immunity in Economic Espionage Case |
McDermott Will & Emery |
| May 8 2025 |
RAW Confusion? No Error Where Trial Court Declines to Clarify Agreed Jury Instruction |
McDermott Will & Emery |
| May 8 2025 |
No Supremacy Clause Preemption Where State Statute Doesn’t Conflict With Federal |
McDermott Will & Emery |
| May 8 2025 |
New Administration, Same Patent Reform Bill |
McDermott Will & Emery |
| May 8 2025 |
“Payment Handler”: A Nonce Term Without Instructions |
McDermott Will & Emery |
| May 8 2025 |
No Green Light to Register Color Mark for Medical Gloves |
McDermott Will & Emery |
| May 8 2025 |
Damages on Default Judgment Not Barred by Absence of Precise Amount in Complaint |
McDermott Will & Emery |
| May 8 2025 |
China Issues the 2025 Intellectual Property Nation Building Promotion Plan To Accelerate the Construction of a Powerful Intellectual Property Country |
Schwegman, Lundberg & Woessner, P.A. |
| May 7 2025 |
USPTO Fees Increasing on January 19, 2025: Key Changes to Note |
Foley & Lardner LLP |
| May 7 2025 |
Global Growth In GenAI Patenting Activity |
Foley & Lardner LLP |
| May 7 2025 |
The Rise of GenAI in Personalized Medicine and Beyond |
Foley & Lardner LLP |
